← Browse by Condition
Medical Condition
dravet syndrome
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Enrollment
150 pts
Location
United States, Canad...
Sponsor
Epygenix
NCT07251673
Recruiting
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Enrollment
50 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan...
Sponsor
Stoke Therapeutics, Inc
NCT06660394 Phase 3
Recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Enrollment
160 pts
Location
United States, Austr...
Sponsor
Longboard Pharmaceuticals
NCT05485831
Recruiting
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
Enrollment
100 pts
Location
Italy
Sponsor
Jazz Pharmaceuticals